Pregnenolone for the treatment of established dyskinesia in Parkinson's disease's disease
MJFF - Michael J.Fox Foundation
Scadenza: 14/03/2024
Ruolo nel progetto: Principal Investigator
Responsabile: Manolo Carta

Targeting the neurovascular unit to prevent dissemination and progression of Parkinson’s disease
MJFF - Michael J.Fox Foundation
Scadenza: sept 2022
Ruolo nel progetto: Subaward
Responsabile: Annarosa Carta

Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
MJFF - Michael J.Fox Foundation
Scadenza: 31/08/2020
Ruolo nel progetto: Subaward
Responsabile: Manolo Carta

A Multicentric Randomized Pragmatic Trial to Compare the Effectiveness of Fingolimod
versus Dimethyl-Fumarate on Patient Overall Disease Experience in Relapsing-Remitting
Multiple Sclerosis: Novel Data to Inform Decision Makers
PCORI - Patient-Centered Outcomes Research Institute
Scadenza: 01/12/2021
Ruolo nel progetto: Beneficiary
Responsabile: Eleonora Cocco

Optimization of efflux avoidance and inhibition for antibiotic development
National Institute of Health - NIH
Scadenza: 31/01/2023
Ruolo nel progetto: Subaward
Responsabile: Paolo Ruggerone

Reversing antibiotic resistance with efflux pump inhibitors
National Health and Medical Research Council – NHMRC
Ruolo nel progetto: Subaward
Responsabile: Paolo Ruggerone

Neurodevelopmental Effects of THC on The VTA Dopamine System and Behavior
NIH-NIDA
Call: PA15-142
Ruolo nel progetto: Subaward
Responsabile: Miriam Melis